COVID-19 Impact on Global Pediatrics Medicine Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pediatrics Medicine Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Enteral
  • 1.4.3 Parenteral
• 1.5 Market by Application
  • 1.5.1 Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
  • 1.5.2 Respiratory diseases
  • 1.5.3 Infectious diseases
  • 1.5.4 Gastrointestinal diseases
  • 1.5.5 CNS diseases
  • 1.5.6 Oncological diseases
  • 1.5.7 CVDs
  • 1.5.8 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Pediatrics Medicine Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Pediatrics Medicine Industry
    • 1.6.1.1 Pediatrics Medicine Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Pediatrics Medicine Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Pediatrics Medicine Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Pediatrics Medicine Market Perspective (2015-2026)
• 2.2 Pediatrics Medicine Growth Trends by Regions
  • 2.2.1 Pediatrics Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pediatrics Medicine Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pediatrics Medicine Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pediatrics Medicine Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pediatrics Medicine Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pediatrics Medicine Players by Market Size
  • 3.1.1 Global Top Pediatrics Medicine Players by Revenue (2015-2020)
  • 3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pediatrics Medicine Market Concentration Ratio
  • 3.2.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2019
• 3.3 Pediatrics Medicine Key Players Head office and Area Served
• 3.4 Key Players Pediatrics Medicine Product Solution and Service
• 3.5 Date of Enter into Pediatrics Medicine Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Pediatrics Medicine Historic Market Size by Type (2015-2020)
• 4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2021-2026)

5 Pediatrics Medicine Breakdown Data by Application (2015-2026)

• 5.1 Global Pediatrics Medicine Market Size by Application (2015-2020)
• 5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pediatrics Medicine Market Size (2015-2020)
• 6.2 Pediatrics Medicine Key Players in North America (2019-2020)
• 6.3 North America Pediatrics Medicine Market Size by Type (2015-2020)
• 6.4 North America Pediatrics Medicine Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pediatrics Medicine Market Size (2015-2020)
• 7.2 Pediatrics Medicine Key Players in Europe (2019-2020)
• 7.3 Europe Pediatrics Medicine Market Size by Type (2015-2020)
• 7.4 Europe Pediatrics Medicine Market Size by Application (2015-2020)

8 China

• 8.1 China Pediatrics Medicine Market Size (2015-2020)
• 8.2 Pediatrics Medicine Key Players in China (2019-2020)
• 8.3 China Pediatrics Medicine Market Size by Type (2015-2020)
• 8.4 China Pediatrics Medicine Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pediatrics Medicine Market Size (2015-2020)
• 9.2 Pediatrics Medicine Key Players in Japan (2019-2020)
• 9.3 Japan Pediatrics Medicine Market Size by Type (2015-2020)
• 9.4 Japan Pediatrics Medicine Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pediatrics Medicine Market Size (2015-2020)
• 10.2 Pediatrics Medicine Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020)

11 India

• 11.1 India Pediatrics Medicine Market Size (2015-2020)
• 11.2 Pediatrics Medicine Key Players in India (2019-2020)
• 11.3 India Pediatrics Medicine Market Size by Type (2015-2020)
• 11.4 India Pediatrics Medicine Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Pediatrics Medicine Market Size (2015-2020)
• 12.2 Pediatrics Medicine Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Pediatrics Medicine Market Size by Type (2015-2020)
• 12.4 Central & South America Pediatrics Medicine Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 GSK
  • 13.1.1 GSK Company Details
  • 13.1.2 GSK Business Overview and Its Total Revenue
  • 13.1.3 GSK Pediatrics Medicine Introduction
  • 13.1.4 GSK Revenue in Pediatrics Medicine Business (2015-2020))
  • 13.1.5 GSK Recent Development
• 13.2 Novartis
  • 13.2.1 Novartis Company Details
  • 13.2.2 Novartis Business Overview and Its Total Revenue
  • 13.2.3 Novartis Pediatrics Medicine Introduction
  • 13.2.4 Novartis Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.2.5 Novartis Recent Development
• 13.3 Pfizer
  • 13.3.1 Pfizer Company Details
  • 13.3.2 Pfizer Business Overview and Its Total Revenue
  • 13.3.3 Pfizer Pediatrics Medicine Introduction
  • 13.3.4 Pfizer Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.3.5 Pfizer Recent Development
• 13.4 Sanofi
  • 13.4.1 Sanofi Company Details
  • 13.4.2 Sanofi Business Overview and Its Total Revenue
  • 13.4.3 Sanofi Pediatrics Medicine Introduction
  • 13.4.4 Sanofi Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.4.5 Sanofi Recent Development
• 13.5 Abbott
  • 13.5.1 Abbott Company Details
  • 13.5.2 Abbott Business Overview and Its Total Revenue
  • 13.5.3 Abbott Pediatrics Medicine Introduction
  • 13.5.4 Abbott Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.5.5 Abbott Recent Development
• 13.6 Bristol-Myers Squibb
  • 13.6.1 Bristol-Myers Squibb Company Details
  • 13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  • 13.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
  • 13.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.6.5 Bristol-Myers Squibb Recent Development
• 13.7 Cipla
  • 13.7.1 Cipla Company Details
  • 13.7.2 Cipla Business Overview and Its Total Revenue
  • 13.7.3 Cipla Pediatrics Medicine Introduction
  • 13.7.4 Cipla Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.7.5 Cipla Recent Development
• 13.8 Eisai Pharmaceuticals
  • 13.8.1 Eisai Pharmaceuticals Company Details
  • 13.8.2 Eisai Pharmaceuticals Business Overview and Its Total Revenue
  • 13.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
  • 13.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.8.5 Eisai Pharmaceuticals Recent Development
• 13.9 Eli Lilly
  • 13.9.1 Eli Lilly Company Details
  • 13.9.2 Eli Lilly Business Overview and Its Total Revenue
  • 13.9.3 Eli Lilly Pediatrics Medicine Introduction
  • 13.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.9.5 Eli Lilly Recent Development
• 13.10 F. Hoffman-La Roche
  • 13.10.1 F. Hoffman-La Roche Company Details
  • 13.10.2 F. Hoffman-La Roche Business Overview and Its Total Revenue
  • 13.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
  • 13.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020)
  • 13.10.5 F. Hoffman-La Roche Recent Development
• 13.11 Glenmark
  • 10.11.1 Glenmark Company Details
  • 10.11.2 Glenmark Business Overview and Its Total Revenue
  • 10.11.3 Glenmark Pediatrics Medicine Introduction
  • 10.11.4 Glenmark Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.11.5 Glenmark Recent Development
• 13.12 Helsinn Healthcare
  • 10.12.1 Helsinn Healthcare Company Details
  • 10.12.2 Helsinn Healthcare Business Overview and Its Total Revenue
  • 10.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
  • 10.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.12.5 Helsinn Healthcare Recent Development
• 13.13 Heron Therapeutics
  • 10.13.1 Heron Therapeutics Company Details
  • 10.13.2 Heron Therapeutics Business Overview and Its Total Revenue
  • 10.13.3 Heron Therapeutics Pediatrics Medicine Introduction
  • 10.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.13.5 Heron Therapeutics Recent Development
• 13.14 Ipca Laboratories
  • 10.14.1 Ipca Laboratories Company Details
  • 10.14.2 Ipca Laboratories Business Overview and Its Total Revenue
  • 10.14.3 Ipca Laboratories Pediatrics Medicine Introduction
  • 10.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.14.5 Ipca Laboratories Recent Development
• 13.15 Lupin Pharmaceuticals
  • 10.15.1 Lupin Pharmaceuticals Company Details
  • 10.15.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
  • 10.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
  • 10.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.15.5 Lupin Pharmaceuticals Recent Development
• 13.16 Merck Sharp & Dohme
  • 10.16.1 Merck Sharp & Dohme Company Details
  • 10.16.2 Merck Sharp & Dohme Business Overview and Its Total Revenue
  • 10.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
  • 10.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.16.5 Merck Sharp & Dohme Recent Development
• 13.17 RedHill
  • 10.17.1 RedHill Company Details
  • 10.17.2 RedHill Business Overview and Its Total Revenue
  • 10.17.3 RedHill Pediatrics Medicine Introduction
  • 10.17.4 RedHill Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.17.5 RedHill Recent Development
• 13.18 Sun Pharmaceutical Industries
  • 10.18.1 Sun Pharmaceutical Industries Company Details
  • 10.18.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
  • 10.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
  • 10.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.18.5 Sun Pharmaceutical Industries Recent Development
• 13.19 Takeda Pharmaceutical
  • 10.19.1 Takeda Pharmaceutical Company Details
  • 10.19.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
  • 10.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
  • 10.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020)
  • 10.19.5 Takeda Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer